[3-(triethoxysilyl)propyl]urea

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

migrated information: read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

key study

Study period:

05 Feb 1996 - 28 June 1996

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: The study was conducted according to an appropriate OECD test guideline, and in compliance with GLP. Since this is a read-across from a structural analogue substance, the reliability was changed from RL1 to RL2.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1996

Report date:

1996

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

Deviations:

yes

Remarks:

(the limit dose tested in the main study was 5000 mg/kg bw)

GLP compliance:

yes

Test type:

standard acute method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

[3-(trimethoxysilyl)propyl]urea

EC Number:

245-904-8

EC Name:

[3-(trimethoxysilyl)propyl]urea

Cas Number:

23843-64-3

IUPAC Name:

1-[3-(trimethoxysilyl)propyl]urea

Details on test material:

- Name of test material (as cited in study report): Silquest Y-11542, gamma-ureidopropyltrimethoxysilane
- Physical state: clear, colorless, slightly viscous liquid
- Lot/batch No.: 2131UG060495
- Expiration date of the lot/batch:
- Specific gravity: 1.14 glml, as determined by WIL Research Laboratories, Inc. pharmacy personnel)
- Storage conditions: original container at room temperature
- Stability under test and storage conditions: Test material stability data are the responsibility of
the Sponsor. Under the conditions employed during the testing of this material, the Sponsor has indicated that the material is stable, provided the sample is not contaminated, is properly sealed, and stored under normal conditions as dictated by good manufacturing practice.

Test animals

Species:

rat

Strain:

other: Albino rat

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Strain: Crl:CD BR
- Source: Charles River Breeding Laboratories, Inc. Portage, MI, USA
- Age at study initiation: young adult
- Weight at study initiation: 231-300 g
- Fasting period before study: 18-20 h prior to dosing and 3-4 h after dosing
- Housing: Individual in suspended wire-mesh cages
- Diet: Purim@ Certified Rodent Chow@ #5002, ad libitum. Analysis of feed was performed and provided by the manufacturer.
- Water: municipal water, ad libitum. Water was analysed in accordance with Standard Operating Procedures.
- Acclimation period: 7 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22.0-22.3 (71.6-72.1 °F)
- Humidity (%): 43.7-50.0
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

unchanged (no vehicle)

Details on oral exposure:

MAXIMUM DOSE VOLUME APPLIED: 4.39 ml/kg bw

DOSAGE PREPARATION:
A sufficient amount of test material was transferred from the original container to a labeled storage vessel. A stir bar was added, and the test material was maintained on a magnetic stir plate prior to dispensation and throughout the dosing procedure.

RATIONALE FOR DOSE SELECTION:
Prior to initiation of the main study, a range-finding study was conducted in which groups of one male and one female rat were dosed at levels of 500, 1000, 2000, 3500 and 5000 mg/kg bw. There were no deaths during the range-finding study. Based on these results, 5000 mglkg was selected as the first level on the main study.

Doses:

Range-finding test: 500, 1000, 2000, 3500 and 5000 mg/kg bw
Main study: 5000 mg/kg bw

No. of animals per sex per dose:

Range-finding test: 1
Main study: 5

Control animals:

other: not required

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations: The rats were observed at approximately 1.0, 3.0 and 4.0 hours post-dose on day 0 and twice daily (morning and afternoon) thereafter for 14 days.
- Frequency of weighing: Body weights were obtained and recorded on study days -1, 0 (initiation), 7 and 14 (termination).
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, and gross pathology (major organ systems of the cranial, thoracic and abdominal cavities for all animals)

Results and discussion

Preliminary study:

There were no deaths during the range-finding study. Based on these results, 5000 mg/kg bw was selected as the first level on the main study.

Effect levels

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 5 000 mg/kg bw

Based on:

test mat.

Remarks on result:

other: No mortality occurred.

Mortality:

There were no deaths during the study.

Clinical signs:

other: Three rats had wet and/or dried yellow urogenital staining. Yellow urogenital staining is a common, non-specific finding in acute studies that, in isolation, is not evidence of significant toxicity. Clear ocular discharge and mucoid faeces were noted for

Gross pathology:

At the terminal necropsy, dark red lungs were noted for three rats. This finding was not considered to be test material-related as it is often noted in animals that have been euthanised by carbon dioxide inhalation. There were no other gross necropsy findings.

Applicant's summary and conclusion

Interpretation of results:

not classified

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

The test material was investigated for acute oral toxicity according to the OECD TG 401, and in compliance with GLP. The undiluted test material was administered once via oral gavage to 5 Crl:CD BR rats each sex at a dose of 5000 mg/kg bw. No mortality occured and no clinical signs were noted throughout the study period. Based on these findings, classification for acute oral toxicity according to 67/584/EEC and EC/1272/2008 is not warranted.